CTI BioPharma Statistics
Total Valuation
Alector has a market cap or net worth of $144.99 million. The enterprise value is -$168.51 million.
Important Dates
The next estimated earnings date is Monday, August 11, 2025, after market close.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Alector has 99.99 million shares outstanding. The number of shares has increased by 13.40% in one year.
| Current Share Class | 99.99M |
| Shares Outstanding | 99.99M |
| Shares Change (YoY) | +13.40% |
| Shares Change (QoQ) | +1.10% |
| Owned by Insiders (%) | 6.65% |
| Owned by Institutions (%) | 64.08% |
| Float | 73.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.61 |
| Forward PS | 15.03 |
| PB Ratio | 1.53 |
| P/TBV Ratio | 1.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.43.
| Current Ratio | 3.34 |
| Quick Ratio | 3.23 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -90.26% and return on invested capital (ROIC) is -51.04%.
| Return on Equity (ROE) | -90.26% |
| Return on Assets (ROA) | -17.22% |
| Return on Invested Capital (ROIC) | -51.04% |
| Return on Capital Employed (ROCE) | -48.16% |
| Revenue Per Employee | $371,172 |
| Profits Per Employee | -$518,660 |
| Employee Count | 238 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Alector has paid $121,000 in taxes.
| Income Tax | 121,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.83% in the last 52 weeks. The beta is 0.74, so Alector's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -75.83% |
| 50-Day Moving Average | 1.52 |
| 200-Day Moving Average | 2.06 |
| Relative Strength Index (RSI) | 41.61 |
| Average Volume (20 Days) | 476,440 |
Short Selling Information
The latest short interest is 5.87 million, so 5.87% of the outstanding shares have been sold short.
| Short Interest | 5.87M |
| Short Previous Month | 6.18M |
| Short % of Shares Out | 5.87% |
| Short % of Float | 7.96% |
| Short Ratio (days to cover) | 11.04 |
Income Statement
In the last 12 months, Alector had revenue of $88.34 million and -$123.44 million in losses. Loss per share was -$1.27.
| Revenue | 88.34M |
| Gross Profit | -86.08M |
| Operating Income | -143.78M |
| Pretax Income | -157.67M |
| Net Income | -123.44M |
| EBITDA | -138.83M |
| EBIT | -143.78M |
| Loss Per Share | -$1.27 |
Full Income StatementBalance Sheet
The company has $354.55 million in cash and $41.05 million in debt, giving a net cash position of $313.50 million or $3.14 per share.
| Cash & Cash Equivalents | 354.55M |
| Total Debt | 41.05M |
| Net Cash | 313.50M |
| Net Cash Per Share | $3.14 |
| Equity (Book Value) | 94.61M |
| Book Value Per Share | 0.95 |
| Working Capital | 256.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$229.34 million and capital expenditures -$742,000, giving a free cash flow of -$230.08 million.
| Operating Cash Flow | -229.34M |
| Capital Expenditures | -742,000 |
| Free Cash Flow | -230.08M |
| FCF Per Share | -$2.30 |
Full Cash Flow StatementMargins
Gross margin is -97.44%, with operating and profit margins of -162.76% and -139.74%.
| Gross Margin | -97.44% |
| Operating Margin | -162.76% |
| Pretax Margin | -139.60% |
| Profit Margin | -139.74% |
| EBITDA Margin | -157.16% |
| EBIT Margin | -162.76% |
| FCF Margin | n/a |
Dividends & Yields
Alector does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.40% |
| Shareholder Yield | -13.40% |
| Earnings Yield | -85.14% |
| FCF Yield | -158.69% |
Analyst Forecast
The average price target for Alector is $4.50, which is 210.35% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.50 |
| Price Target Difference | 210.35% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 5.32% |
| EPS Growth Forecast (5Y) | -17.03% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Alector has an Altman Z-Score of -2.43 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.43 |
| Piotroski F-Score | 1 |
